Hydrocortisone Butyrate Ointment
Product Images NDC 68682-271

2 FDA label images from Oceanside Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrocortisone Butyrate (NDC 68682-271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hydrocortisone-butyrate-figure-1-hydrocortisone_butyrate_structure.jpg (Hydrocortisone Butyrate Ointment 1)

Hydrocortisone-butyrate-figure-1-hydrocortisone_butyrate_structure.jpg (Hydrocortisone Butyrate Ointment 1)
Chemical structure of hydrocortisone butyrate, a corticosteroid active ingredient, showing its molecular arrangement with carbon, hydrogen, and oxygen atoms labeled in standard chemical notation.*
FDA Label Image

Image 01

Image 01
Hydrocortisone Butyrate 0.1% ointment packaging label for topical use, containing 45 g net weight. The label indicates it is Rx only and not for ophthalmic use. Distributed by Oceanside Pharmaceuticals, manufactured by Ferndale Laboratories, and shows a blue gradient background with the Oceanside Pharmaceuticals logo. The label includes directions for dosage and storage temperature instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.